Creatinine‐Based Renal Function Assessment in Pediatric Drug Development: An Analysis Using Clinical Data for Renally Eliminated Drugs-Reference-Cited by-同舟云学术

Creatinine‐Based Renal Function Assessment in Pediatric Drug Development: An Analysis Using Clinical Data for Renally Eliminated Drugs

Published:2020-08-29 Issue:1 Volume:109 Page:263-269
ISSN:0009-9236
Container-title:Clinical Pharmacology & Therapeutics
language:en
Short-container-title:Clin. Pharmacol. Ther.

Author:

Zhang Yifei¹,Sherwin Catherine M.²,Gonzalez Daniel³,Zhang Qunshu¹,Khurana Mona⁴,Fisher Jeffrey⁵,Burckart Gilbert J.⁶,Wang Yaning⁶,Yao Lynne P.⁴,Ganley Charles J.¹,Wang Jian¹

Affiliation:

1. Office of Drug Evaluation IV Office of New Drugs Center for Drug Evaluation and Research US Food and Drug Administration Silver Spring Maryland USA

2. Department of Pediatrics Wright State University School of Medicine Dayton Children’s Hospital Dayton Ohio USA

3. Division of Pharmacotherapy and Experimental Therapeutics UNC Eshelman School of Pharmacy University of North Carolina at Chapel Hill Chapel Hill North Carolina USA

4. Division of Pediatric and Maternal Health Office of Drug Evaluation IV Center for Drug Evaluation and Research US Food and Drug Administration Silver Spring Maryland USA

5. Division of Biochemical Toxicology National Center for Toxicological Research US Food and Drug Administration Jefferson Arkansas USA

6. Office of Clinical Pharmacology Office of Translational Sciences Center for Drug Evaluation and Research US Food and Drug Administration Silver Spring Maryland USA

Funder

U.S. Food and Drug Administration

National Institute of Child Health and Human Development

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cpt.1991

Reference19 articles.

1. US Food and Drug Administration (FDA).Drugs@FDA: FDA Approved Drug Products. Accessed July 15 2019.

2. AUC-Guided Vancomycin Dosing in Adolescent Patients With Suspected Sepsis